NCT03690791View on ClinicalTrials.gov

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

PHASE3UnknownINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

December 30, 2023

Study Completion Date

January 30, 2024

Conditions
Amyotrophic Lateral SclerosisMotor Neuron Disease
Interventions
DRUG

MediCabilis CBD Oil

50 mg of CBD: \<2mg of THC in one ml. The cannabis oil consists of CBD extract in MCT oil.

DRUG

Placebo Oil

Placebo will contain only hemp seed oil.

Trial Locations (1)

4215

Gold Coast Hospital and Health Service, Gold Coast

Sponsors

Collaborators (1)

Bod Australia
All Listed Sponsors
collaborator

Bod Australia

INDUSTRY

lead

Gold Coast Hospital and Health Service

OTHER_GOV

NCT03690791 - Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease | Biotech Hunter | Biotech Hunter